Patients with Von Hippel-Lindau disease are unable to regulate this physical process because they can no longer downregulate HIF1?.  Commonly studied in vitro with the tube-forming assay, this process may be inhibited by antibodies against vascular endothelial growth factor.  While this process is important in wound healing and in the female reproductive cycle, it is also important pathologically in tumor growth. * FTP, identify this biological process that creates new b
Patients with Von Hippel-Lindau disease are unable to regulate this physical process because they can no longer downregulate HIF1?.  Commonly studied in vitro with the tube-forming assay, this process may be inhibited by antibodies against vascular endothelial growth factor.  While this process is important in wound healing and in the female reproductive cycle, it is also important pathologically in tumor growth. * FTP, identify this biological process that creates new blood vessels from pre-existing vessels.
Patients with Von Hippel-Lindau disease are unable to regulate this physical process because they can no longer downregulate HIF1?.  
angiogenesis (prompt on vasculogenesis before "tumor growth")